Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.1 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |